FDA NDC Directory · JSON-LD · Markdown

ODEFSEY

NDC 61958-2101 · HUMAN PRESCRIPTION DRUG · TABLET

Generic nameemtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide
Labeler / ManufacturerGilead Sciences, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA208351
Dosage form / routeTABLET · ORAL
Active ingredientsEMTRICITABINE (200 mg/1)
RILPIVIRINE HYDROCHLORIDE (25 mg/1)
TENOFOVIR ALAFENAMIDE FUMARATE (25 mg/1)
Marketing started20160301
Package count1

External sources

Source: openFDA. Public-domain (CC0).